BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26067143)

  • 1. Decline in Antigenicity of Tumor Markers by Storage Time Using Pathology Sections Cut From Tissue Microarrays.
    Blows FM; Ali HR; Dawson SJ; Le Quesne J; Provenzano E; Caldas C; Pharoah PD
    Appl Immunohistochem Mol Morphol; 2016 Mar; 24(3):221-6. PubMed ID: 26067143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of antigenicity in stored sections of breast cancer tissue microarrays.
    Fergenbaum JH; Garcia-Closas M; Hewitt SM; Lissowska J; Sakoda LC; Sherman ME
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):667-72. PubMed ID: 15066936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality Assessment of Proteins and RNA Following Storage in Archival Formalin-Fixed Paraffin-Embedded Human Breast Cancer Tissue Microarray Sections.
    Kim K; Ylaya K; Perry C; Lee MY; Kim JW; Chung JY; Hewitt SM
    Biopreserv Biobank; 2023 Oct; 21(5):493-503. PubMed ID: 36264172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections.
    Muftah AA; Aleskandarany MA; Al-Kaabi MM; Sonbul SN; Diez-Rodriguez M; Nolan CC; Caldas C; Ellis IO; Rakha EA; Green AR
    Breast Cancer Res Treat; 2017 Jul; 164(2):341-348. PubMed ID: 28478613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Storage Conditions and Immunoreactivity of Breast Cancer Subtyping Markers in Tissue Microarray Sections.
    Omilian AR; Zirpoli GR; Cheng TD; Yao S; Stein L; Davis W; Head KL; Nair P; Khoury T; Ambrosone CB; Bshara W
    Appl Immunohistochem Mol Morphol; 2020 Apr; 28(4):267-273. PubMed ID: 31205070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER2 in gastric cancer: comparative analysis of three different antibodies using whole-tissue sections and tissue microarrays.
    Abrahão-Machado LF; Jácome AA; Wohnrath DR; dos Santos JS; Carneseca EC; Fregnani JH; Scapulatempo-Neto C
    World J Gastroenterol; 2013 Oct; 19(38):6438-46. PubMed ID: 24151362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miniature tissue microarrays for HercepTest standardisation and analysis.
    Gulmann C; Loring P; O'Grady A; Kay E
    J Clin Pathol; 2004 Nov; 57(11):1229-31. PubMed ID: 15509692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays.
    Stopsack KH; Tyekucheva S; Wang M; Gerke TA; Vaselkiv JB; Penney KL; Kantoff PW; Finn SP; Fiorentino M; Loda M; Lotan TL; Parmigiani G; Mucci LA
    Elife; 2021 Dec; 10():. PubMed ID: 34939926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term preservation of antigenicity on tissue microarrays.
    DiVito KA; Charette LA; Rimm DL; Camp RL
    Lab Invest; 2004 Aug; 84(8):1071-8. PubMed ID: 15195116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue microarrays: one size does not fit all.
    Eckel-Passow JE; Lohse CM; Sheinin Y; Crispen PL; Krco CJ; Kwon ED
    Diagn Pathol; 2010 Jul; 5():48. PubMed ID: 20609235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of tissue microarray biomarker expression of breast carcinomas in Saudi women.
    Alkushi A
    Hematol Oncol Stem Cell Ther; 2009; 2(3):394-8. PubMed ID: 20139052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer.
    Jacobs TW; Prioleau JE; Stillman IE; Schnitt SJ
    J Natl Cancer Inst; 1996 Aug; 88(15):1054-9. PubMed ID: 8683636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays.
    Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
    J Clin Pathol; 2007 Apr; 60(4):397-404. PubMed ID: 16775123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Biomarkers-Comparison on Whole Section and Tissue Microarray Section.
    Chavan SS; Ravindra S; Prasad M
    J Clin Diagn Res; 2017 Mar; 11(3):EC40-EC44. PubMed ID: 28511394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased D2-40 immunoreactivity in stored paraffin sections and methods for preserving it.
    Sasaki T; Kawabata Y; Suzuki N; Tanaka H; Sano M; Kato S; Takemura A; Unno N; Kojima T; Sato K
    Biotech Histochem; 2014 Aug; 89(6):412-8. PubMed ID: 24939609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of methods for preserving PTEN antigenicity in stored paraffin sections.
    Gelb AB; Freeman VA; Astrow SH
    Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):569-73. PubMed ID: 21552118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of storage time of paraffin sections on the expression of PD-L1 (SP142) in invasive breast cancer.
    He J; Wang X; Cai L; Jia Z; Liu C; Sun X; Wu S; Ding C; Zhang Z; Liu Y
    Diagn Pathol; 2023 Dec; 18(1):131. PubMed ID: 38053121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How Long Are Unstained Sections Available for Immunostaining? -A Study of Antigenicity Preservation Time-].
    Inoue S; Matsuki Y; Mori M
    Rinsho Byori; 2016 Nov; 64(11):1215-1219. PubMed ID: 30695301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical evaluation of the effects of paraffin section storage on biomarker stability.
    Ramos-Vara JA; Webster JD; DuSold D; Miller MA
    Vet Pathol; 2014 Jan; 51(1):102-9. PubMed ID: 23435571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a low-cost modified technique for constructing tissue microarrays for canine mammary tumor analysis.
    Silva FB; Leite Jda S; de Mello MF; Ferreira AM
    Pathol Res Pract; 2016 Sep; 212(9):783-90. PubMed ID: 27461825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.